Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth Presented in part as a poster presentation at the 35th Annual Society of Maternal Fetal Medicine Meeting, San Diego, CA, February 2-7, 2015.

American Journal of Obstetrics and Gynecology

Volumn 214, Issue 3, 2016, Pages 376.e1-376.e8

  Manuck, Tracy A ^a,b   Esplin, M Sean ^a,b   Biggio, Joseph ^c   Bukowski, Radek ^d   Parry, Samuel ^e   Zhang, Heping ^f   Huang, Hao ^f   Varner, Michael W ^a,b   Andrews, William ^c   Saade, George ^d   Sadovsky, Yoel ^g   Reddy, Uma M ^h   Ilekis, John ^h  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c Division of Maternal Fetal Medicine   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f YALE UNIVERSITY   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

decidual hemorrhage; progesterone; recurrent preterm birth; spontaneous preterm labor

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; ANTIESTROGEN; PROGESTERONE DERIVATIVE;

ADULT; ARTICLE; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PREMATURE LABOR; PRIORITY JOURNAL; SECONDARY ANALYSIS; VAGINA BLEEDING; ABRUPTIO PLACENTAE; CLINICAL TRIAL; GENETICS; HIGH RISK PREGNANCY; LONGITUDINAL STUDY; MULTICENTER STUDY; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; TREATMENT FAILURE; UTERINE HEMORRHAGE; YOUNG ADULT;

ABRUPTIO PLACENTAE; ADULT; ESTROGEN ANTAGONISTS; FEMALE; GESTATIONAL AGE; HUMANS; HYDROXYPROGESTERONES; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TREATMENT FAILURE; UTERINE HEMORRHAGE; YOUNG ADULT;

EID: 85014539229     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.12.010     Document Type: Article

References (21)

1. C.N. Schoen, S. Tabbah, J.D. Iams, A.B. Caughey, and V. Berghella Why the United States preterm birth rate is declining Am J Obstet Gynecol 213 2015 175 180
2. J.J. Henderson, O.A. McWilliam, J.P. Newnham, and C.E. Pennell Preterm birth aetiology 2004-2008. Maternal factors associated with three phenotypes: spontaneous preterm labour, preterm pre-labour rupture of membranes and medically indicated preterm birth J Matern Fetal Neonatal Med 25 2012 642 647
3. M.M. Adams, L.D. Elam-Evans, H.G. Wilson, and D.A. Gilbertz Rates of and factors associated with recurrence of preterm delivery JAMA 283 2000 1591 1596
4. M.S. Esplin, E. O'Brien, A. Fraser, and et al. Estimating recurrence of spontaneous preterm delivery Obstet Gynecol 112 2008 516 523
5. S.E. Simonsen, J.L. Lyon, J.B. Stanford, C.A. Porucznik, M.S. Esplin, and M.W. Varner Risk factors for recurrent preterm birth in multiparous Utah women: a historical cohort study BJOG 120 2013 863 872
6. J. McManemy, E. Cooke, E. Amon, and T. Leet Recurrence risk for preterm delivery Am J Obstet Gynecol 196 2007 576.e1 576.e7
7. P.J. Meis, M. Klebanoff, E. Thom, and et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385
8. T.A. Manuck, W.S. Watkins, B. Moore, and et al. Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention Am J Obstet Gynecol 210 2014 321.e1 321.e21
9. T.A. Manuck, Y. Lai, P.J. Meis, and et al. Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate Am J Obstet Gynecol 205 2011 135.e1 135.e9
10. D.M. Ramaeker, and H.N. Simhan Sonographic cervical length, vaginal bleeding, and the risk of preterm birth Am J Obstet Gynecol 206 2012 224.e1 224.e4
11. J.A. McPherson, A.O. Odibo, A.L. Shanks, K.A. Roehl, G.A. Macones, and A.G. Cahill Adverse outcomes in twin pregnancies complicated by early vaginal bleeding Am J Obstet Gynecol 208 2013 56.e1 56.e5
12. J.A. Lykke, K.L. Dideriksen, O. Lidegaard, and J. Langhoff-Roos First-trimester vaginal bleeding and complications later in pregnancy Obstet Gynecol 115 2010 935 944
13. J.E. Tyson, N.A. Parikh, J. Langer, and et al. Intensive care for extreme prematurity-moving beyond gestational age N Engl J Med 358 2008 1672 1681
14. K. Mikkola, N. Ritari, V. Tommiska, and et al. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997 Pediatrics 116 2005 1391 1400
15. C.S. Phibbs, and S.K. Schmitt Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants Early Hum Dev 82 2006 85 95
16. S.L. Bloom, N.P. Yost, D.D. McIntire, and K.J. Leveno Recurrence of preterm birth in singleton and twin pregnancies Obstet Gynecol 98 2001 379 385
17. V.H. Gonzalez-Quintero, Y.C. Cordova, N.B. Istwan, and et al. Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery Am J Obstet Gynecol 205 2011 275.e1 275.e5
18. S. Coleman, L. Wallace, J. Alexander, and N. Istwan Recurrent preterm birth in women treated with 17 alpha-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy J Matern Fetal Neonatal Med 25 2012 1034 1038
19. C.Y. Spong, P.J. Meis, E.A. Thom, and et al. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery Am J Obstet Gynecol 193 2005 1127 1131
20. A. Rebarber, L.A. Ferrara, M.L. Hanley, and et al. Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate Am J Obstet Gynecol 196 2007 224.e1 224.e4
21. K.B. Markham, H. Walker, C.D. Lynch, and J.D. Iams Preterm birth rates in a prematurity prevention clinic after adoption of progestin prophylaxis Obstet Gynecol 123 2014 34 39